Загрузка страницы

Three-Year Outcomes in High-Risk Patients Undergoing SAVR or TAVR

Michael Reardon, MD
Is the Distinguished Chair of Cardiovascular Research and Professor of Cardiovascular Surgery, DeBakey Heart & Vascular Center at Houston’s Methodist Hospital. He discusses this paper, presented as featured researh at ACC.16 and now published in JACC. This interview was conducted by CSWN at ACC.16 in Chicago.

Further reading:

Deeb GM, Reardon MJ, Chetcuti S, et al. J Am Coll Cardiol. 2016;67(22):2565-74.

http://content.onlinejacc.org/article.aspx?articleid=2506791

Видео Three-Year Outcomes in High-Risk Patients Undergoing SAVR or TAVR канала CSWNews
Показать
Комментарии отсутствуют
Введите заголовок:

Введите адрес ссылки:

Введите адрес видео с YouTube:

Зарегистрируйтесь или войдите с
Информация о видео
3 июня 2016 г. 18:52:48
00:06:55
Яндекс.Метрика